CDC- BRFSS – ACBS 2022 Adult Prevalence Table 5
State/Territory | Current | |||
---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | |
Arizona | 326 | 4.2 | 1.2 | (1.8 – 6.6) |
California | 305 | 15.4 | 4.3 | (7.0 – 23.8) |
Connecticut | 495 | 8.1 | 2.2 | (3.8 – 12.4) |
Florida | 458 | 13.0 | 2.9 | (7.3 – 18.7) |
Georgia | 330 | 10.8 | 2.7 | (5.5 – 16.1) |
Hawaii | 204 | N/A | N/A | (N/A – N/A) |
Indiana | 477 | 7.5 | 1.6 | (4.4 – 10.6) |
Iowa | 289 | 5.5 | 1.6 | (2.4 – 8.6) |
Kansas | 231 | 10.1 | 2.6 | (5.0 – 15.2) |
Maine | 358 | N/A | N/A | (N/A – N/A) |
Maryland | 391 | 10.2 | 2.7 | (4.9 – 15.5) |
Massachusetts | 335 | 4.7 | 1.4 | (2.0 – 7.4) |
Michigan | 507 | 7.0 | 1.7 | (3.7 – 10.3) |
Minnesota | 537 | 6.4 | 1.3 | (3.9 – 8.9) |
Missouri | 240 | N/A | N/A | (N/A – N/A) |
Nebraska | 159 | N/A | N/A | (N/A – N/A) |
New Hampshire | 384 | 5.3 | 1.5 | (2.4 – 8.2) |
New Jersey | 299 | N/A | N/A | (N/A – N/A) |
New Mexico | 161 | N/A | N/A | (N/A – N/A) |
New York | 318 | 8.0 | 2.4 | (3.3 – 12.7) |
Ohio | 410 | N/A | N/A | (N/A – N/A) |
Oregon | 139 | N/A | N/A | (N/A – N/A) |
Rhode Island | 238 | 12.7 | 3.1 | (6.6 – 18.8) |
Texas | 281 | 9.8 | 2.7 | (4.5 – 15.1) |
Utah | 308 | 9.9 | 2.4 | (5.2 – 14.6) |
Vermont | 504 | 7.4 | 1.7 | (4.1 – 10.7) |
Wisconsin | 396 | 6.0 | 1.3 | (3.5 – 8.5) |
Puerto Rico | 259 | 8.5 | 2.5 | (3.6 – 13.4) |
28 States / Area | 9,339 | 9.4 | 0.9 | (7.6 – 11.2) |
Median | 8.1 | |||
Range | 4.2-15.4 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2022/pdf/sdq_report_acbs_22-508.pdf